Back to Woodline Partners LP Woodline Partners LP

ATYRATYR

Showing 6 of 8 quarters

Position history for Woodline Partners LPWoodline Partners LP's holdings in aTyr Pharma, Inc.

No. Woodline Partners exited its ATYR (aTyr Pharma) position in Q4 2025. Its Q3 2025 13F listed 102,687 shares worth $74,078. Woodline Partners first reported ATYR in Q1 2024 and held it in 7 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$3M

Total Shares Change

-1.7M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$0.78
0
2025-Q3
Decreased
102,687
-93.9%
$74,0780.0%$0.72
0
2025-Q2
Unchanged
1.7M
0.0%
$8.5M0.0%$5.07
0
2025-Q1
Decreased
1.7M
-0.1%
$5.1M0.0%$3.02
0
2024-Q4
Decreased
1.7M
-0.0%
$6.1M0.0%$3.62
0
2024-Q3
Increased
1.7M
+0.0%
$3M0.0%$1.76
26

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used